PATENT CLAIM ANALYSIS

Application Number: 15985334
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["514", "002000"]

Abstract:
The present invention describes compositions and methods for treating cardiovascular disease and myocardial infarction using dipeptidyl peptidase inhibitors. Also provided are methods for increasing natriuretic peptide function by administering one or more analogues of B type natriuretic peptide that provide increased stability in the presence of prolyl-specific dipeptidyl peptidases.

Claim (Index 19):
The method of  claim 1 , wherein the first and/or second antibodies are each conjugated to a detectable label.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 93.0
- Lexical Diversity: 1.18605
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15293262', '10938760', '10827919', '15269423', '13132493']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.803781600492037
- 35 USC 102 Novelty (BERT): 0.5153532695361103
- Combined Prediction Score: 0.7749387673964443
- Mean Citation Score: 250.32855
- Max Citation Score: 362.18124
- Similarity Product: 300.3554941932678

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test